RBC Capital analyst Daniel Perlin raised the firm’s price target on Global Payments (GPN) to $139 from $130 and keeps an Outperform rating on ...
RBC Capital lowered the firm’s price target on Biogen (BIIB) to $225 from $231 but keeps an Outperform rating on the shares after its Q4 ...
The prospect of a growing trade war isn’t just a risk to Canada’s industries, it also poses a threat to the Canadian housing market, says RBC Economics.
Investing.com -- RBC Capital Markets analysts have expressed a cautious outlook on Smiths Group 's (LON: SMIN) stock, citing limited upside potential despite the company’s decision to pursue a partial ...
Following the company’s second quarter results, RBC analyst Drew McReynolds has raised his price target on WildBrain.
RBC was the buyer, beefing up its position in personal and ... “Our investments to strengthen our governance and control structure, core operations and anti-money laundering measures will position us ...
RBC Capital Markets reiterated its Outperform rating on Adobe (NASDAQ:ADBE) stock with a steadfast price target of $590.00, ...
IN a recent paper, Dervichian, Fournet and Guinier describe experiments on the low-angle scattering of X-rays from red blood cells 1. They show that the scattering curve can be explained as being ...
RBC Capital Markets updated its outlook on Fortive Corporation (NYSE:FTV), a diversified industrial technology conglomerate with a market capitalization of $27.5 billion, by increasing the price ...
While Royal Bank focused on dealmaking in the U.S., its biggest domestic rival, TD, embraced retail banking — a 'cutthroat' business south of the border — sowing the seeds of their diverging fortunes ...
Good morning and thank you for joining us for RBC Bearings’ Fiscal Third Quarter 2025 Earnings Call. I am Rob Moffatt, Director of Corporate Development and Investor Relations. And with me on today’s ...